Vancouver, BC – January 20, 2015, Aurora Cannabis Inc. (CSE: ACB) (Frankfurt: 21P; WKN: A1C4WM) (“Aurora” or the "Company") is pleased to announce the appointments of Dr. Trevor MacMillan, Ken Faulkner and Paul Searle to Aurora’s management team.
Dr. Trevor MacMillan, Research and Development Manager
Dr. MacMillan brings with him an impressive background in plant breeding, biotechnology and regulatory environments. He will be an integral part of Aurora’s Scientific Team which held its first meeting at Aurora’s production facility on December 12, 2014. Details regarding this team will be released once finalized.
Dr. MacMillan graduated from the University of Saskatchewan with a Bachelor of Science in Biochemistry in 2001. In 2014, he completed his PhD in Agricultural Plant Biotechnology at the University of Lethbridge. His post graduate career began with Agriculture and Agri-Food Canada and Health Canada in waterborne photogene isolation and characterization. Following this, Dr. MacMillan was previously employed by the Department of National Defense at Defense Research and Development Canada (DRDC) where he was instrumental in developing molecular detection assays for bacterial bio-threat agents. Additionally, he worked as the Good Laboratory Practices (GLP) implementation coordinator for DRDC for a GLP compliant facility performing regulatory drug studies. Later, he was employed by the Canadian Food Inspection Agency (CFIA) as a senior molecular research technologist.
Ken Faulkner, Director of Corporate Development
Mr. Faulkner has an extensive background in the public markets where he has structured and formed the future of many public companies in a wide range of sectors. Mr. Faulkner has also acted as a consultant for various public and private companies. In this capacity, he has helped these companies acquire financing and analytical following as well as with property acquisition and joint venture opportunities. He has served as a Director, President and CEO of various Canadian public companies.
Since 1980, Mr. Faulkner’s experience in the public markets has allowed him to establish an extensive database of international relationships with investment banks and market analysts. This gives him the capacity and wherewithal to fulfill a proactive role in the future growth of a company in any stage of development.
Most recently, Mr. Faulkner has focused his efforts in the North American MMJ sector. Although a relatively new industry, Mr. Faulkner has cultivated relationships on both sides of the 49th parallel that have synergy in relation to funding and acquisitions in an industry where creating critical mass is paramount.
Paul Searle, Investor Relations Manager
Mr. Searle has been in the public markets for over 18 years. He is an experienced strategic IR Manager who has raised over $150 million in a broad range of industries for public companies. He is fully capable of integrating finance, communication, marketing and securities law compliance between the Company, the financial community and regulatory authorities. Recently, Mr. Searle played a key role in establishing a following for the Green Rush conferences that were held in Vancouver and Toronto.
Terry Booth, CEO, states: “We are delighted to welcome Trevor, Ken and Paul to the Aurora Team. All three have already contributed to raising the bar on the “Aurora Standard”. Trevor brings a wealth of knowledge and will now drive the R&D end of our business. Ken will be instrumental in creating critical mass and Paul will communicate with our investors the plans that are in place to swiftly move Aurora into the upper echelon of cannabis companies in North America”.
Aurora continues to build a versatile team of professionals which will ensure that it will become one of the industry leaders in the emerging medical marijuana market place. These additions come at a time when Aurora is in the final stages of receiving its Licensed Producer designation from Health Canada pursuant to the Marihuana for Medical Purposes Regulation.
On behalf of the Board of Directors,
AURORA CANNABIS INC.
“Terry Booth”
Terry Booth
CEO
Certain information in this press release may constitute forward-looking information. This information is based on current expectations that are subject to significant risks and uncertainties that are difficult to predict. Actual results might differ materially from results suggested in any forward-looking statements. The Company assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward looking-statements unless and until required by securities laws applicable to the Company. Additional information identifying risks and uncertainties is contained in the Company’s filings with the Canadian securities regulators, which filings are available at www.sedar.com.
The CSE has not reviewed, approved or disapproved the contents of this press release. We seek Safe Harbor.